A61K 31/726
Glycosaminoglycans, i.e. mucopolysaccharides
Official title: Glycosaminoglycans, i.e. mucopolysaccharides (chondroitin sulfate, dermatan sulfate A61K31/737)
A61K31/726 (Glycosaminoglycans, i.e. mucopolysaccharides) appears on 2,061 US grants and 3,768 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,061
- Published applications
- 3,768
- Assignees
- 1,610
- Inventors
- 5,602
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 11 | 0 |
| 1997 | 26 | 0 |
| 1998 | 34 | 0 |
| 1999 | 38 | 0 |
| 2000 | 39 | 0 |
| 2001 | 22 | 12 |
| 2002 | 32 | 59 |
| 2003 | 39 | 90 |
| 2004 | 22 | 86 |
| 2005 | 26 | 111 |
| 2006 | 34 | 139 |
| 2007 | 24 | 139 |
| 2008 | 34 | 101 |
| 2009 | 33 | 95 |
| 2010 | 46 | 128 |
| 2011 | 54 | 135 |
| 2012 | 57 | 136 |
| 2013 | 91 | 162 |
| 2014 | 129 | 222 |
| 2015 | 115 | 199 |
| 2016 | 130 | 187 |
| 2017 | 105 | 185 |
| 2018 | 101 | 181 |
| 2019 | 130 | 178 |
| 2020 | 110 | 191 |
| 2021 | 111 | 187 |
| 2022 | 108 | 198 |
| 2023 | 107 | 200 |
| 2024 | 74 | 180 |
| 2025 | 97 | 131 |
| 2026 | 64 | 136 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Surface treatment of contact lens and treatment of ocular discomfort by water soluble polymers and lipids/liposomes22 Sep 2026US 12,740,942 B2Yeda Research and Development Co. Ltd.
- Fish swim bladder-derived heparin-like mucopolysaccharide and methods of making and using the same22 Sep 2026US 12,740,998 B2Guangdong Ocean University
- Eye care composition containing l-ergothioneine, and preparation method therefor and use thereof15 Sep 2026US 12,734,154 B2Gene III Biotechnology Co., Ltd.
- Delayed release oral pharmaceutical composition8 Sep 2026US 12,728,097 B2Aihol Corporation
- Method of preparing hyaluronic acid nanoparticles8 Sep 2026US 12,728,100 B2Amorepacific Corporation
- Novel glycan compounds for age-related macular degeneration8 Oct 2026US 2026/0306530 A1The Regents of the University of California
- Combination therapy comprising a composition of mesenchymal stromal cells and hyaluronic acid for use in treatment of osteoarthritis8 Oct 2026US 2026/0306547 A1Stempeutics Research Private Limited
- Surface modified ophthalmic devices1 Oct 2026US 2026/0294680 A1Bausch + Lomb Ireland Limited
- Composition for the treatment of osteoarthrosis1 Oct 2026US 2026/0294958 A1Abiogen Pharma S.P.A.
- Topical composition for the treatment of mucosal lesions with short gelling time1 Oct 2026US 2026/0294959 A1Inmedical Therapeutics, S.L.
Most cited
By later US patents
- Modified hyaluronic acid for use in musculoskeletal tissue repair805US 7,091,191 B2Ethicon, Inc. · 2006
- Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor777US 8,734,831 B2Snu R&Db Foundation · 2014
- Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like367US 6,387,379 B1University of Florida · 2002
- Polymer compositions containing bioactive agents and methods for their use299US 6,770,729 B2Medtronic MiniMed, Inc. · 2004
- Coatings for medical devices285US 6,746,773 B2Ethicon, Inc. · 2004